The use of transdermal fentanyl in palliative care.
Morphine is recognised as the strong opioid of choice for the treatment of moderate to severe cancer pain. In some cases an alternative strong opioid is required - transdermal fentanyl represents a new option for the pharmacological treatment of pain at Step 3 of the World Health Organisation (WHO) analgesic ladder (WHO 1986). This paper aims to provide a practical overview of the use of this new method of delivering strong opioid analgesia in a patient population requiring palliative care.